1. Home
  2. JELD vs SEER Comparison

JELD vs SEER Comparison

Compare JELD & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JELD-WEN Holding Inc.

JELD

JELD-WEN Holding Inc.

HOLD

Current Price

$1.14

Market Cap

94.9M

ML Signal

HOLD

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$1.90

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JELD
SEER
Founded
1960
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Forest Products
Medicinal Chemicals and Botanical Products
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.9M
97.3M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
JELD
SEER
Price
$1.14
$1.90
Analyst Decision
Hold
Analyst Count
6
0
Target Price
$3.43
N/A
AVG Volume (30 Days)
2.1M
143.0K
Earning Date
05-04-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.40
EPS
N/A
N/A
Revenue
$3,211,181,000.00
$16,578,000.00
Revenue This Year
N/A
$2.14
Revenue Next Year
$2.31
$25.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.99
52 Week Low
$0.93
$1.65
52 Week High
$6.98
$2.41

Technical Indicators

Market Signals
Indicator
JELD
SEER
Relative Strength Index (RSI) 38.43 66.36
Support Level N/A $1.90
Resistance Level $2.06 $1.97
Average True Range (ATR) 0.11 0.05
MACD 0.03 0.02
Stochastic Oscillator 54.55 89.62

Price Performance

Historical Comparison
JELD
SEER

About JELD JELD-WEN Holding Inc.

JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential and non-residential buildings. The firm's operating segments are North America, and Europe. It generates a majority of its revenue from North America.

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

Share on Social Networks: